Determinants of Timely Treatment in Women with Breast Cancer Supported by Six Non-governmental Organizations in Colombia

Authors

  • Guillermo Sánchez University Foundation of Health Sciences
  • Carlos G. Niño University Foundation of Health Sciences
  • Ana C. Estupiñán SIMMON Foundation

DOI:

https://doi.org/10.17533/udea.rfnsp.v34n3a04

Keywords:

breast neoplasms, health services accessibility, health services research, social organization, socioeconomic factors, Colombia

Abstract

Objective: to establish the percentage of timely treatments and their determinants in a group of Colombian women with breast cancer supported by six non-governmental organizations. Methodology: An analytical observational study was performed which included women with breast cancer supported by six non-governmental organizations in Colombia. Data were gathered retrospectively via surveys and triangulation of
documents to establish the course of care. Results: a total of 240 women were included, 17.1% of which had been treated in time. Health services were denied to 30.4% of the women, and legal actions to claim the right to health (named “tutelas” in Spanish) were taken by 31.2% of the women. The multivariate analysis established that a schooling level beyond high school is related to timely access to treatment. (OR: 3.62; p value: 0.001). Discussion: in Colombia, timely access to breast cancer treatment is socially determined and schooling level plays an important role.
|Abstract
= 589 veces | PDF (ESPAÑOL (ESPAÑA))
= 281 veces|

Downloads

Download data is not yet available.

Author Biographies

Guillermo Sánchez, University Foundation of Health Sciences

PhD in Public Health, Master in Clinical Epidemiology. University Foundation of Health Sciences,  San José Hospital. Colombia.

Carlos G. Niño, University Foundation of Health Sciences

Doctor. University Foundation of Health Sciences. Colombia.

Ana C. Estupiñán, SIMMON Foundation

Nurse specialist in epidemiology. SIMMON Foundation. Colombia.

References

(1). IARC. GLOBOCAN: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. [Internet] France: IARC, WHO; 2012 [Acceso 11 de Febrero de 2014]. Disponible en: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx

(2). Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94(2):153-156.

(3). Ministerio de Salud y Protección Social. Plan Decenal de Salud Pública. 2012-2021. Bogotá: El Ministerio; 2013.

(4). Ministerio de Salud y Protección Social. Plan Decenal Para el Control del Cáncer 2012 - 2021. Bogotá: El Ministerio: 2013.

(5). Instituto Nacional de Cancerología. Anuario Estadístico 2010. Bogotá: INC; 2012.

(6). Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159):1119-1126.

(7). Arndt V, Sturmer T, Stegmaier C, Ziegler H, Becker A, Brenner H. Provider delay among patients with breast cancer in Germany: A population-based study. Journal of Clinical Oncology. 2003;21(8):1440-1446.

(8). Pineros M, Sánchez R, Perry F, García OA, Ocampo R, Cendales R. [Delay for diagnosis and treatment of breast cancer in Bogota, Colombia]. Demoras en el diagnostico y tratamiento de mujeres con cancer de mama en Bogota, Colombia. 2011;53(6):478-485.

(9). Abadia CE, Oviedo DG. Bureaucratic Itineraries in Colombia. A theoretical and methodological tool to assess managed-care health care systems. Soc Sci Med. 2009;68(6):1153-1160.

(10). Hansen RP, Vedsted P, Sokolowski I, Sondergaard J, Olesen F. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC health services research. 2011;11(101088677):284.

(11). Pineros M, Sanchez R, Cendales R, Perry F, Ocampo R. Patient delay among Colombian women with breast cancer. Salud Publica Mex. 2009;51(5):372-380.

(12). De Charry L, Carrasquilla G, Roca S. Equidad en la detección del cáncer de seno en Colombia. Rev Salud Publica. 2008;10(4):571-582.

(13). Asívamosensalud.org. Aseguramiento. Bogotá: Fundación Santa Fé de Bogotá; 2012. Disponible en: http://www.asivamosensalud.org/inidicadores/aseguramiento/grafica.ver/15.

(14). Ibrahim NA, Oludara MA. Socio-demographic factors and reasons associated with delay in breast cancer presentation: a study in Nigerian women. Breast. 2012;21(3):416-418.

(15). Chintamani, Tuteja A, Khandelwal R, Tandon M, Bamal R, Jain S, et al. Patient and provider delays in breast cancer patients attending a tertiary care. JRSM Short Rep. 2011;2(10):76.

(16). Sánchez G. Cáncer de piel no melanoma: riesgos e itinerarios. Bogotá: Universidad Nacional de Colombia; 2013.

(17). Price AJ, Ndom P, Atenguena E, Mambou Nouemssi JP, Ryder RW. Cancer care challenges in developing countries. Cancer. 2012;118(14):3627-3635.

(18). Alhurishi S, Lim JNW, Potrata B, West R. Factors influencing late presentation for breast cancer in the middle east: A systematic review. Asian Pacific Journal of Cancer Prevention. 2011;12(6):1597-1600.

(19). Mosunjac M, Park J, Strauss A, Birdsong G, Du V, Rizzo M, et al. Time to treatment for patients receiving BCS in a public and a private university hospital in Atlanta. Breast J. 2012;18(2):163-167.

(20). Colombia. El Congreso de la República. Ley 1384 de 2010: “Ley Sandra Ceballos”, Ley Sandra Ceballos, por la cual se establecen las acciones para la atención integral del cáncer en Colombia. Bogotá: El Congreso; 2010.

Published

2016-09-05

How to Cite

1.
Sánchez G, Niño CG, Estupiñán AC. Determinants of Timely Treatment in Women with Breast Cancer Supported by Six Non-governmental Organizations in Colombia. Rev. Fac. Nac. Salud Pública [Internet]. 2016 Sep. 5 [cited 2025 Jan. 22];34(3):297-305. Available from: https://revistas.udea.edu.co/index.php/fnsp/article/view/20087